References:
- Munro M, Yadavalli T, Fonteh C, Arfeen S, Lobo-Chan AM.
Cytomegalovirus Retinitis in HIV and Non-HIV
Individuals. Microorganisms . 2019;8(1):55. Published 2019 Dec
28. doi:10.3390/microorganisms8010055
- Boeckh M, Ljungman P. How we treat cytomegalovirus in hematopoietic
cell transplant recipients. Blood . 2009;113(23):5711-5719.
doi:10.1182/blood-2008-10-143560
- Kim JY, Hong SY, Park WK, et al. Prognostic factors of cytomegalovirus
retinitis after hematopoietic stem cell transplantation. PLoS
One . 2020;15(9):e0238257. Published 2020 Sep 2.
doi:10.1371/journal.pone.0238257
- Mori T, Kikuchi T, Koh M, et al. Cytomegalovirus retinitis after
allogeneic hematopoietic stem cell transplantation under
cytomegalovirus antigenemia-guided active screening. Bone Marrow
Transplant . 2021;56(6):1266-1271. doi:10.1038/s41409-020-01176-8
- Larsson K, Lönnqvist B, Ringdén O, Hedquist B, Ljungman P. CMV
retinitis after allogeneic bone marrow transplantation: a report of
five cases. Transpl Infect Dis . 2002;4(2):75-79.
doi:10.1034/j.1399-3062.2002.01018.x
- Crippa F, Corey L, Chuang EL, Sale G, Boeckh M. Virological, clinical,
and ophthalmologic features of cytomegalovirus retinitis after
hematopoietic stem cell transplantation. Clin Infect Dis .
2001;32(2):214-219. doi:10.1086/318447
- Einsele H, Ljungman P, Boeckh M. How I treat CMV reactivation after
allogeneic hematopoietic stem cell transplantation. Blood .
2020;135(19):1619-1629. doi:10.1182/blood.2019000956
- Vassallo F, Nuzzi R, Cattani I, et al. CMV retinitis in a stem cell
transplant recipient treated with foscarnet intravitreal injection and
CMV specific immunoglobulins. Ther Adv Hematol .
2020;11:2040620720975651. Published 2020 Dec 10.
doi:10.1177/2040620720975651
- Marty FM, Ljungman P, Chemaly RF, et al. Letermovir Prophylaxis for
Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J
Med . 2017;377(25):2433-2444. doi:10.1056/NEJMoa1706640